NASDAQ: PARKPark Dental Partners Inc Stock
$20.43-0.06 (-0.29%)
Updated Sep 4, 2026
PARK Price
$20.43
Fair Value Price
N/A
Market Cap
$97.15M
52 Week Low
$9.53
52 Week High
$26.03
P/E
-8.88x
P/B
3.26x
P/S
0.39x
PEG
N/A
Dividend Yield
N/A
Revenue
$251.37M
Earnings
-$3.54M
Gross Margin
11.1%
Operating Margin
-2.81%
Profit Margin
-1.4%
Debt to Equity
5.25
Operating Cash Flow
$18M
Beta
0.59
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
PARK Overview
Park Dental Partners, Inc. operates as a dental support organization, providing a wide array of non-clinical and operational assistance to dental professionals throughout Minnesota and Wisconsin. The company furnishes its network of affiliated general and multi-specialty dental practices with vital resources, including clinical and administrative staff, physical facilities, and essential equipment. Through these partnered clinics, patients can access a full spectrum of oral healthcare services, from general dentistry to specialized procedures such as oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics. Founded in 1972, Park Dental Partners, Inc. is headquartered in Roseville, Minnesota.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PARK's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +17.17% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
A
PARK
Ranked#10 of 44
Ranked#10 of 44
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $519.84 | A | |
| $265.05 | A | |
| $27.03 | B |
Be the first to know about important PARK news, forecast changes, insider trades & much more!
PARK News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PARK scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PARK is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PARK is good value based on its book value relative to its share price (3.26x), compared to the US Medical Care Facilities industry average (5.44x)
P/B vs Industry Valuation
PARK is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more PARK due diligence checks available for Premium users.
Valuation
PARK price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-8.88x
Industry
17.14x
Market
40.74x
PARK price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.26x
Industry
5.44x
PARK is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PARK's financial health
Profit margin
Revenue
$66.2M
Net Income
$1.3M
Profit Margin
2%
PARK's Earnings (EBIT) of -$7.08M... subscribe to Premium to read more.
Interest Coverage Financials
PARK's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$186.3M
Liabilities
$156.4M
Debt to equity
5.25
PARK's short-term assets ($39.65M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PARK's long-term liabilities ($121.15M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PARK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$4.7M
Investing
-$3.4M
Financing
-$1.2M
PARK's operating cash flow ($18.11M)... subscribe to Premium to read more.
Debt Coverage Financials
PARK vs Medical Care Facility Stocks
Park Dental Partners Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.